{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:05:05Z","timestamp":1768449905561,"version":"3.49.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T00:00:00Z","timestamp":1448236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0143429","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T21:27:48Z","timestamp":1448400468000},"page":"e0143429","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV\/HCV Coinfection"],"prefix":"10.1371","volume":"10","author":[{"given":"Bernhard","family":"Scheiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattias","family":"Mandorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Schwabl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berit Anna","family":"Payer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Bucsics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Bota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian C.","family":"Aichelburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Grabmeier-Pfistershammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"St\u00e4ttermayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ferenci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Peck-Radosavljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,11,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","article-title":"Epidemiology of viral hepatitis and HIV co-infection","volume":"44","author":"MJ Alter","year":"2006","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/imr.12063","article-title":"HIV and co-infections","volume":"254","author":"CC Chang","year":"2013","journal-title":"Immunol Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"T Poynard","year":"1997","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.23136","article-title":"Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus\/hepatitis C virus","volume":"50","author":"J Macias","year":"2009","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1365-2893.2009.01197.x","article-title":"HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension","volume":"17","author":"T Reiberger","year":"2010","journal-title":"J Viral Hepat"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"MS Sulkowski","year":"2014","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1517\/14656566.2014.934810","article-title":"Latest pharmacotherapy options for treating hepatitis C in HIV-infected patients","volume":"15","author":"J Macias","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"ref8","article-title":"Chronic Hepatitis C in the era of novel interferon-free all-oral regimens: treat everyone now or stratify by disease?","author":"T Reiberger","year":"2014","journal-title":"Minerva Gastroenterol Dietol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3851\/IMP2816","article-title":"Progression to advanced liver fibrosis in HIV-HCV-coinfected patients and prioritization of new hepatitis C therapies","volume":"19","author":"P Labarga","year":"2014","journal-title":"Antivir Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/infdis\/jir113","article-title":"Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy","volume":"203","author":"P Barreiro","year":"2011","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1038\/ncomms7422","article-title":"Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease","volume":"6","author":"M Eslam","year":"2015","journal-title":"Nat Commun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/QAD.0b013e32830e6d51","article-title":"Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis","volume":"22","author":"HH Thein","year":"2008","journal-title":"AIDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/501021","article-title":"Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3","volume":"42","author":"P Barreiro","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/QAD.0b013e32835aa161","article-title":"Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients","volume":"27","author":"M Mandorfer","year":"2013","journal-title":"AIDS"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/hep.27445","article-title":"Patatin-like phospholipase domain-containing protein 3 and Liver Disease: Opportunities to Unravel Mechanisms Underlying Statistical Associations","volume":"61","author":"J Boursier","year":"2015","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MOL.0b013e328338ca61","article-title":"Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein","volume":"21","author":"S Romeo","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","article-title":"Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase","volume":"15","author":"M Kumari","year":"2012","journal-title":"Cell Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"S Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"ref19","article-title":"Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C","author":"K Yasui","year":"2014","journal-title":"J Gastroenterol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ajg.2013.476","article-title":"The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis","volume":"109","author":"AG Singal","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/apt.12717","article-title":"Review article: genetic factors that modify the outcome of viral hepatitis","volume":"39","author":"AF Stattermayer","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ajg.2014.32","article-title":"Risk factors for fatty liver in the Multicenter AIDS Cohort Study","volume":"109","author":"JC Price","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hep.24350","article-title":"Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C","volume":"54","author":"E Trepo","year":"2011","journal-title":"Hepatology"},{"key":"ref24","article-title":"Revisiting liver disease progression in HIV\/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3","author":"M Mandorfer","year":"2014","journal-title":"Liver Int"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2362.2011.02623.x","article-title":"IL28B and interferon-gamma inducible protein 10 for prediction of rapid virologic response and sustained virologic response in HIV-HCV-coinfected patients","volume":"42","author":"BA Payer","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jhep.2011.11.008","article-title":"Prediction of response to pegylated interferon plus ribavirin in HIV\/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load","volume":"56","author":"K Neukam","year":"2012","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"ref27","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/modpathol.3800693","article-title":"Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach","volume":"20","author":"ND Theise","year":"2007","journal-title":"Mod Pathol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"L Castera","year":"2005","journal-title":"Gastroenterology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jhep.2010.07.033","article-title":"Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy","volume":"54","author":"EA Tsochatzis","year":"2011","journal-title":"J Hepatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2893.2011.01534.x","article-title":"Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan((R)): validation in chronic hepatitis C","volume":"19","author":"M Sasso","year":"2012","journal-title":"J Viral Hepat"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3851\/IMP2349","article-title":"A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin","volume":"17","author":"T Reiberger","year":"2012","journal-title":"Antivir Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00001574-200105000-00012","article-title":"Portal hypertension","volume":"17","author":"G Garcia-Tsao","year":"2001","journal-title":"Curr Opin Gastroenterol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S1665-2681(19)30842-7","article-title":"PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C","volume":"13","author":"J Ampuero","year":"2014","journal-title":"Ann Hepatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00508-013-0337-z","article-title":"Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II)","volume":"125","author":"M Peck-Radosavljevic","year":"2013","journal-title":"Wien Klin Wochenschr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/liv.12253","article-title":"Health-related quality of life and severity of fatigue in HIV\/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin","volume":"34","author":"M Mandorfer","year":"2014","journal-title":"Liver Int"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/hep.26741","article-title":"Fibrosis progression in human immunodeficiency virus\/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs","volume":"59","author":"MA Konerman","year":"2014","journal-title":"Hepatology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/hiv.12082","article-title":"Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV\/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration","volume":"15","author":"L Castera","year":"2014","journal-title":"HIV Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00508-012-0190-5","article-title":"Noninvasive screening for liver fibrosis and portal hypertension by transient elastography\u2014a large single center experience","volume":"124","author":"T Reiberger","year":"2012","journal-title":"Wien Klin Wochenschr"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.24123","article-title":"Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C","volume":"53","author":"L Valenti","year":"2011","journal-title":"Hepatology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2012.04.036","article-title":"Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C","volume":"57","author":"AF Stattermayer","year":"2012","journal-title":"J Hepatol"},{"key":"ref41","article-title":"Non-alcoholic Steatohepatitis and Hepatic Fibrosis in Human Immunodeficiency Virus-1 Mono-infected Adults with Elevated Transaminases on Antiretroviral Therapy","author":"CG Morse","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1053\/j.gastro.2009.06.040","article-title":"Coinfection with HIV-1 and HCV\u2014a one-two punch","volume":"137","author":"AY Kim","year":"2009","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"ref43","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/infdis\/jis926","article-title":"Pathogenesis of accelerated fibrosis in HIV\/HCV co-infection","volume":"207","author":"W Lin","year":"2013","journal-title":"J Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/jhep.2001.24432","article-title":"Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity","volume":"33","author":"LE Adinolfi","year":"2001","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"ref45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2036.2005.02597.x","article-title":"Review article: hepatitis C virus-associated steatosis\u2014pathogenic mechanisms and clinical implications","volume":"22","author":"LE Adinolfi","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.22134","article-title":"Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus\/hepatitis C virus coinfection","volume":"47","author":"RK Sterling","year":"2008","journal-title":"Hepatology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"M Sasso","year":"2010","journal-title":"Ultrasound Med Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.aids.0000163935.99401.25","article-title":"Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus","volume":"19","author":"MS Sulkowski","year":"2005","journal-title":"AIDS"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.aids.0000210606.63138.f5","article-title":"Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors","volume":"20","author":"F Bani-Sadr","year":"2006","journal-title":"AIDS"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/jvh.12118","article-title":"Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-\/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels","volume":"21","author":"M Mandorfer","year":"2014","journal-title":"J Viral Hepat"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2362.2008.01958.x","article-title":"Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection","volume":"38","author":"T Reiberger","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1365-2036.2012.05109.x","article-title":"Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin","volume":"35","author":"L Valenti","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/jvh.12053","article-title":"Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C","volume":"20","author":"R Zampino","year":"2013","journal-title":"J Viral Hepat"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0143429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T21:34:10Z","timestamp":1567373650000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0143429"}},"subtitle":[],"editor":[{"given":"Golo","family":"Ahlenstiel","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,23]]},"references-count":53,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0143429","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,23]]}}}